Expansion of the Yaroslavl plant of finished dosage forms and biotechnological substances
PROJECT OVERVIEW
14 000 m2of production facilities
650 million units produced per year
The Yaroslavl plant of final dosage forms and biotechnological substances is a multifunctional site, the center of R-Pharm'sproduction and logistics operations in Russia. It produces different medicines, some of them under license agreements with the world's leading pharmaceutical companies.
The R-Pharmplant in Yaroslavl is one of the few Russian manufacturers of monoclonal antibodies, active substances of biological nature used to treat dangerous diseases.
The project provides for the construction of four stand-alone buildings connected by a transport gallery, with the installation of on-site utilities.
Project Period:
2020–2022
MISSIONS OF SETEC INGINIRING
- General design
- Stage P and detail design documentation development
- 3D BIM model development
- Getting approvals from the competent regulatory authorities
- Designer supervision
Client:
R-PharmJSC